Cargando…
Developments in the formulation and delivery of spray dried vaccines
Spray drying is a promising method for the stabilization of vaccines, which are usually formulated as liquids. Usually, vaccine stability is improved by spray drying in the presence of a range of excipients. Unlike freeze drying, there is no freezing step involved, thus the damage related to this st...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647985/ https://www.ncbi.nlm.nih.gov/pubmed/28925794 http://dx.doi.org/10.1080/21645515.2017.1356952 |
_version_ | 1783272322785869824 |
---|---|
author | Kanojia, Gaurav Have, Rimko ten Soema, Peter C. Frijlink, Henderik Amorij, Jean-Pierre Kersten, Gideon |
author_facet | Kanojia, Gaurav Have, Rimko ten Soema, Peter C. Frijlink, Henderik Amorij, Jean-Pierre Kersten, Gideon |
author_sort | Kanojia, Gaurav |
collection | PubMed |
description | Spray drying is a promising method for the stabilization of vaccines, which are usually formulated as liquids. Usually, vaccine stability is improved by spray drying in the presence of a range of excipients. Unlike freeze drying, there is no freezing step involved, thus the damage related to this step is avoided. The edge of spray drying resides in its ability for particles to be engineered to desired requirements, which can be used in various vaccine delivery methods and routes. Although several spray dried vaccines have shown encouraging preclinical results, the number of vaccines that have been tested in clinical trials is limited, indicating a relatively new area of vaccine stabilization and delivery. This article reviews the current status of spray dried vaccine formulations and delivery methods. In particular it discusses the impact of process stresses on vaccine integrity, the application of excipients in spray drying of vaccines, process and formulation optimization strategies based on Design of Experiment approaches as well as opportunities for future application of spray dried vaccine powders for vaccine delivery. |
format | Online Article Text |
id | pubmed-5647985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-56479852017-11-01 Developments in the formulation and delivery of spray dried vaccines Kanojia, Gaurav Have, Rimko ten Soema, Peter C. Frijlink, Henderik Amorij, Jean-Pierre Kersten, Gideon Hum Vaccin Immunother Review Spray drying is a promising method for the stabilization of vaccines, which are usually formulated as liquids. Usually, vaccine stability is improved by spray drying in the presence of a range of excipients. Unlike freeze drying, there is no freezing step involved, thus the damage related to this step is avoided. The edge of spray drying resides in its ability for particles to be engineered to desired requirements, which can be used in various vaccine delivery methods and routes. Although several spray dried vaccines have shown encouraging preclinical results, the number of vaccines that have been tested in clinical trials is limited, indicating a relatively new area of vaccine stabilization and delivery. This article reviews the current status of spray dried vaccine formulations and delivery methods. In particular it discusses the impact of process stresses on vaccine integrity, the application of excipients in spray drying of vaccines, process and formulation optimization strategies based on Design of Experiment approaches as well as opportunities for future application of spray dried vaccine powders for vaccine delivery. Taylor & Francis 2017-09-19 /pmc/articles/PMC5647985/ /pubmed/28925794 http://dx.doi.org/10.1080/21645515.2017.1356952 Text en © 2017 The Author(s). Published with license by Taylor & Francis http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Review Kanojia, Gaurav Have, Rimko ten Soema, Peter C. Frijlink, Henderik Amorij, Jean-Pierre Kersten, Gideon Developments in the formulation and delivery of spray dried vaccines |
title | Developments in the formulation and delivery of spray dried vaccines |
title_full | Developments in the formulation and delivery of spray dried vaccines |
title_fullStr | Developments in the formulation and delivery of spray dried vaccines |
title_full_unstemmed | Developments in the formulation and delivery of spray dried vaccines |
title_short | Developments in the formulation and delivery of spray dried vaccines |
title_sort | developments in the formulation and delivery of spray dried vaccines |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647985/ https://www.ncbi.nlm.nih.gov/pubmed/28925794 http://dx.doi.org/10.1080/21645515.2017.1356952 |
work_keys_str_mv | AT kanojiagaurav developmentsintheformulationanddeliveryofspraydriedvaccines AT haverimkoten developmentsintheformulationanddeliveryofspraydriedvaccines AT soemapeterc developmentsintheformulationanddeliveryofspraydriedvaccines AT frijlinkhenderik developmentsintheformulationanddeliveryofspraydriedvaccines AT amorijjeanpierre developmentsintheformulationanddeliveryofspraydriedvaccines AT kerstengideon developmentsintheformulationanddeliveryofspraydriedvaccines |